| Schedule of Segment Reporting Information, by Segment |
The following table is a comparative summary of the Company’s net sales and segment profit by reportable segment for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
Three Months Ended |
| |
June 30,
2021 |
June 30,
2020 |
|
June 30,
2021 |
|
June 30,
2020 |
Segment Net Sales:
|
|
|
|
|
|
|
|
| Cannabinoid |
$ |
1,256
|
|
|
$ |
395 |
|
|
$ |
579
|
|
|
$ |
153 |
|
| Non-Cannabinoid |
5,893
|
|
|
4,458 |
|
|
3,093
|
|
|
1,786 |
|
| Total Net Sales |
7,149
|
|
|
4,853 |
|
|
3,672
|
|
|
1,939 |
|
| |
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
| Cannabinoid |
(6,468) |
|
|
(9,855) |
|
|
(3,604) |
|
|
(4,454) |
|
| Non-Cannabinoid |
1,246
|
|
|
413 |
|
|
634
|
|
|
(67) |
|
| Total Segment Loss |
$ |
(5,222) |
|
|
$ |
(9,442) |
|
|
$ |
(2,970) |
|
|
$ |
(4,521) |
|
| |
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
| Total Segment Loss |
(5,222) |
|
|
(9,442) |
|
|
(2,970) |
|
|
(4,521) |
|
| Unallocated corporate expenses |
(6,173) |
|
|
(3,945) |
|
|
(2,786) |
|
|
(2,141) |
|
| Non-cash share based compensation |
(4,873) |
|
|
(713) |
|
|
(3,323) |
|
|
(297) |
|
| Depreciation and amortization |
(1,103) |
|
|
(717) |
|
|
(524) |
|
|
(365) |
|
|
|
|
|
|
|
|
|
| Goodwill impairment |
—
|
|
|
(1,682) |
|
|
—
|
|
|
— |
|
| Loss from operations |
$ |
(17,371) |
|
|
$ |
(16,499) |
|
|
$ |
(9,603) |
|
|
$ |
(7,325) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on fair value of derivative instrument |
—
|
|
|
— |
|
|
—
|
|
|
(13) |
|
| Loss(gain) on remeasurement of warrant liability |
3,675
|
|
|
— |
|
|
(1,176) |
|
|
— |
|
| Loss on investments |
—
|
|
|
228 |
|
|
—
|
|
|
67 |
|
| Foreign exchange loss |
839
|
|
|
359 |
|
|
80
|
|
|
311 |
|
| Interest expense |
1,898
|
|
|
1,789 |
|
|
920
|
|
|
953 |
|
| Miscellaneous, net |
(1,087) |
|
|
48 |
|
|
(485) |
|
|
105 |
|
| Loss before loss from equity investment |
$ |
(22,696) |
|
|
$ |
(18,923) |
|
|
$ |
(8,942) |
|
|
$ |
(8,748) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
2021 |
|
December 31,
2020 |
Long-lived assets
|
|
|
|
| Cannabinoid |
$ |
28,528
|
|
|
$ |
25,485 |
|
Non-Cannabinoid |
151
|
|
|
176 |
|
Other(a)
|
25
|
|
|
19 |
|
| |
$ |
28,704
|
|
|
$ |
25,680 |
|
(a)“Other” includes long-lived assets primarily in the Company’s corporate offices.
|
| Disaggregation of Revenue by Channel |
The following table disaggregates the Company’s revenues by channel for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
Three Months Ended |
|
June 30,
2021 |
|
June 30,
2020 |
|
June 30,
2021 |
|
June 30,
2020 |
| Mass retail |
$ |
3,609
|
|
|
$ |
2,033 |
|
|
$ |
1,721
|
|
|
$ |
1,012 |
|
| Specialty, health and other retail |
575
|
|
|
910 |
|
|
350
|
|
|
598 |
|
| Distributors |
2,680
|
|
|
1,575 |
|
|
1,448
|
|
|
236 |
|
| E-commerce |
285
|
|
|
335 |
|
|
153
|
|
|
93 |
|
|
$ |
7,149
|
|
|
$ |
4,853 |
|
|
$ |
3,672
|
|
|
$ |
1,939 |
|
|